Cargando…
Low-Density Lipoprotein Receptor Is a Key Driver of Aggressiveness in Thyroid Tumor Cells
We previously described the role of low-density lipoprotein (LDL) in aggressiveness in papillary thyroid cancer (PTC). Moreover, the MAPK signaling pathway in the presence of BRAF V600E mutation is associated with more aggressive PTC. Although the link between MAPK cascade and LDL receptor (LDLR) ex...
Autores principales: | Revilla, Giovanna, Ruiz-Auladell, Lara, Vallverdú, Núria Fucui, Santamaría, Paula, Moral, Antonio, Pérez, José Ignacio, Li, Changda, Fuste, Victoria, Lerma, Enrique, Corcoy, Rosa, Pitoia, Fabián, Escolà-Gil, Joan Carles, Mato, Eugènia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342163/ https://www.ncbi.nlm.nih.gov/pubmed/37446330 http://dx.doi.org/10.3390/ijms241311153 |
Ejemplares similares
-
Cross-Talk between Inflammatory Mediators and the Epithelial Mesenchymal Transition Process in the Development of Thyroid Carcinoma
por: Revilla, Giovanna, et al.
Publicado: (2019) -
Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior
por: Revilla, Giovanna, et al.
Publicado: (2023) -
Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness
por: Revilla, Giovanna, et al.
Publicado: (2019) -
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
por: Julve, Josep, et al.
Publicado: (2021) -
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
por: Julve, Josep, et al.
Publicado: (2021)